Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study.
about
Preliminary data on the use of apheresis in inflammatory bowel disease.Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease.Cytapheresis in patients with severe ulcerative colitis after failure of intravenous corticosteroid: a long-term retrospective cohort study.Therapeutic effect of intensive granulocyte and monocyte adsorption apheresis combined with thiopurines for steroid- and biologics-naïve Japanese patients with early-diagnosed Crohn's disease.Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytesLooking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA.Efficacy, safety and cost analyses in ulcerative colitis patients undergoing granulocyte and monocyte adsorption or receiving prednisolone.Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease.Cytapheresis as a Non-Pharmacological Therapy for Inflammatory Bowel Disease.Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis.Peripheral Blood CD64 Levels Decrease in Crohn's Disease following Granulocyte and Monocyte Adsorptive ApheresisSelective bloodletting for severe ulcerative colitis.An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's diseaseInfliximab- and immunosuppressant-resistant Crohn's disease successfully treated with adsorptive granulocyte apheresis combined with prednisoloneDevelopments in the apheresis procedure for the treatment of inflammatory bowel disease.Adsorptive granulocyte/monocyte apheresis for the maintenance of remission in patients with ulcerative colitis: a prospective randomized, double blind, sham-controlled clinical trial.Evolving knowledge and therapy of inflammatory bowel disease.Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitisNeutrophil-dependent oxidative stress in ulcerative colitisTherapeutic landscape for ulcerative colitis: where is the Adacolumn(®) system and where should it be?Cytapheresis in inflammatory bowel diseases: current evidence and perspectives.Value of colonoscopy for prediction of prognosis in patients with ulcerative colitisRegulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis.Granulocytapheresis in the treatment of patients with active ulcerative colitis.Therapeutic options in acute severe ulcerative colitis.Efficacy of granulocyte and monocyte apheresis for antibiotic-refractory pouchitis after proctocolectomy for ulcerative colitis: an open-label, prospective, multicentre study.Granulocyte and monocyte adsorptive apheresis ameliorates sepsis in rats.Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.Current status and future perspectives of leukocytapheresis for inflammatory bowel disease.Leukocytapheresis: An "Out-of-Body" Experience in Inflammatory Bowel Disease.Granulocyte-monocyte adsorptive apheresis in pediatric inflammatory bowel disease: results, practical issues, safety, and future perspectives.Mucosal healing of esophageal involvement of Crohn's disease with granulocyte/monocyte adsorption.Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility study.Leukocyte apheresis in the management of ulcerative colitis.Is Adsorptive Granulocyte and Monocyte Apheresis Effective as an Alternative Treatment Option in Patients with Ulcerative Colitis?The efficacy and safety of selective leukocytapheresis in the treatment of ulcerative colitis: a meta-analysis.Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis.Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis.
P2860
Q31027618-DBE2BB97-72AA-4DFE-81A8-958AD9B17E8FQ33626027-19B75FBE-6064-4159-BB07-4E67D9FE3BD0Q33855532-74A1C1ED-4C8B-4878-8AFA-FFD2C174B911Q33926396-097A2629-BDF8-4624-AFDF-30CAB600B489Q34008773-408A59B0-72BF-43F3-A427-DC9488FE3BDCQ34122035-234B4202-5D66-47AB-A4D2-3D4536EFE180Q34160719-CE4EE3C1-7709-47F7-A037-FF1982EF417EQ34582547-9E343D8C-7933-4C5C-9D83-6811A3DAC336Q34604561-F2B6AC40-DF44-43AA-8221-7E729D773B6BQ34647681-58008B19-DF63-4EDE-A099-D4E4B1E3E29FQ34870365-08B0581A-1F31-46ED-A849-9BD01A9068CAQ35010974-599BBA43-48B2-4F0E-B96F-3317DCC6842CQ35649449-F8EB94D4-FEDE-4B47-8C2B-A905E4471FF3Q35793552-254D60F2-6C8D-4BBA-B16C-C40467B08A56Q35846531-DCF06E77-F2EF-41EE-8DD4-FD945261DF14Q36072095-9460EE27-2EC4-434A-9109-75125F98066FQ36353616-B0E5C42D-5E87-49C0-8140-8664FA5A474BQ36385158-B5879A4D-D868-4E2F-A6A4-BA0478FE632BQ36414506-16275AC2-1922-4CD1-AF56-401C1A8ABAC4Q36474506-06BD9BBF-D1F4-410C-9964-BEE5462CE29AQ36508776-FE83805F-7EBC-4048-AACE-88E4BA8EBE1EQ36522931-B6CFE0CF-6E0D-4E28-BD5F-E1AC8D87838AQ37125624-E39C0151-0402-44A7-B02E-2063AEA82D3FQ37136938-0CF60146-F005-435B-AC6B-7FFB67FEE747Q37220846-053AE3FF-9A06-4219-9DCF-7C948D5E89CFQ37345830-93B59D7C-E737-4F33-B659-42589CDA44E7Q37345935-BD075A05-C24D-4EC8-95E7-2AA7B021F407Q37632264-00F286E6-FBFA-4190-85EA-1BA3885431BAQ37721753-CFACE997-8382-4894-AF4C-0D491403A30BQ37839573-E50AE183-EEDE-431C-B1FB-F6A8AA527C32Q37993226-830EB893-CCD5-4FB3-927B-5CCBDAC5B416Q39194640-00A2E830-6155-4D15-B6C5-2548E2FA2F85Q40010943-CC8BE58E-D4B6-4AB8-B09F-AF0857551DEEQ40317388-744BF14F-3B9B-4F59-90B1-2E5FFCF4CCE4Q40321418-B48B1236-0186-45F6-84AE-5E02C879859EQ41992829-B80CBA2D-DB18-4615-83CF-776754226A51Q42316823-85BB0791-C7A1-40E2-BFAB-DE1DBD4FB4D3Q42596650-ABF3E49C-EC33-4894-A371-2C5D5FC4AA44Q42704574-B984CA4F-4252-4BC3-9366-04E550EB17F5Q42726307-5AF375FE-219A-4907-84B5-6B09604536F9
P2860
Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Safety and efficacy of granulo ...... colitis: a multicenter study.
@en
Safety and efficacy of granulo ...... colitis: a multicenter study.
@nl
type
label
Safety and efficacy of granulo ...... colitis: a multicenter study.
@en
Safety and efficacy of granulo ...... colitis: a multicenter study.
@nl
prefLabel
Safety and efficacy of granulo ...... colitis: a multicenter study.
@en
Safety and efficacy of granulo ...... colitis: a multicenter study.
@nl
P2093
P356
P1476
Safety and efficacy of granulo ...... colitis: a multicenter study.
@en
P2093
Hiwatashi N
Kashiwagi N
Kasukawa R
Matsueda K
Munakata A
P356
10.1002/JCA.1000
P577
2001-01-01T00:00:00Z